Surprising histological findings on the resected specimen of the omentum due to a strangulated umbilical hernia
Authors:
M. Ševčíková; P. Hladík; R. Lischke
Authors‘ workplace:
III. chirurgická klinika 1. LF Univerzity Karlovy a FN Motol, Praha
přednosta: prof. MUDr. R. Lischke, Ph. D.
Published in:
Rozhl. Chir., 2017, roč. 96, č. 12, s. 517-520.
Category:
Case Report
Overview
Introduction:
Gastrointestinal stromal tumor, GIST, is the most common mesenchymal tumor of the digestive system. It most often grows from the stomach or the small intestine and tends to be asymptomatic. The basic and the only curative therapy is an attempt at R0 resection.
If the tumor is inoperable, metastatic or when neoadjuvant or adjuvant therapy is needed, patients are treated with a tyrosine kinase inhibitor - imatinib. It was discovered in 2000 on the basis of GIST molecular behavior.
Case report:
The case report describes a female patient who had been without any clinical symptoms for a long time until she presented with acute abdominal pain due to squeezed umbilical hernia. She underwent an acute operation, resection of the strangulated omentum and reconstruction of the abdominal wall. The omentum was sent for definitive histology. However, the pathologist described nonspecific sarcoma. A subsequent CT scan showed a large tumor mass in the abdominal cavity and in the small pelvis. A multidisciplinary team of the Motol Teaching Hospital indicated the patient for an attempt at radical tumor extirpation. Omentectomy, resection of the jejunum, hysterectomy, right adnexectomy, low anterior resection of the rectum and omphalectomy were performed. The result of the definitive histological examination was high-risk, malignant GIST, c-kit-positive, growing from the jejunum.
Key words:
GIST − gastrointestinal stromal tumor − KIT − imatinib
Sources
1. Gold JS, Dematteo RP. Combined surgical and molecular therapy: the gastrointestinal stromal tumor model. Annals of surgery 2006;244:176−84.
2. Thomas RM, Sobin LH. Gastrointestinal cancer. Cancer 1995;75(suppl 1):154–70.
3. Smolarek S, Pomeroy E, Kinnarney F, et al. Laparoscopic resection of large gastric gastrointestinal stromal tumours. Wideochir Inne Tech Maloinwazyjne 2016; 11:31–7.
4. Mucciarini C, Rossi G, Bertolini F, et al. Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study. BMC Cancer 2007;20:230.
5. DeMatteo RP, Lewiss JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Annals of surgery 2000;231:51−8.
6. Poveda A, Rivera F, Martín J. Spanish Group for Sarcoma Research (GEIS) SEOM (Spanish Society of Clinical Oncology) guidelines for gastrointestinal stromal sarcomas (GIST). Clinical and translational oncology 2012;14:536−40.
7. Gaal J, Stratakis CA, Carney JA, et al. SDHB immunohistochemistry: a useful tool in the diagnosis of Carney-Stratakis and Carney triad gastrointestinal stromal tumors. Mod Pathol 2011;24:147–151.
8. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279:577–80.
9. McCarter MD, Antonescu CR, Ballman KV, et al. American College of Surgeons Oncology Group (ACOSOG), Intergroup Adjuvant GIST Study Team. Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence. J Am Coll Surg 2012;215:53–9
10. Bareck E, Ba-Ssalamah A, Brodowicz T, et al. Gastrointestinal stromal tumors: diagnosis, therapy and follow-up care in Austria. Wien Med Wochenschr 2013;163:137–52
11. Pierie J-PEN, Choudry U, Muzikansky A, et al. The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg 2001;136:383–9.
12. Agaimy A, Wunsch PH. Lymph node metastasis in gastrointestinal stromal tumours (GIST) occurs preferentially in young patients ≤40 years: an overview based on our case material and the literature. Langenbecks Arch Surg 2009;394:375–81
13. Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med. 2001;344:1052–6
14. Analýza registru GIST k 1. 11. 2016. ReGISTer: GIST 217. Available from: http://gist.registry.cz/index.php?pg=analyzy--analyza-registru-gist-k-1-11-2016
15. The ESMO / European Sarcoma Network Working Group. Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Annals of Oncology 2012; 23 (suppl_7):vii49-vii55.
Labels
Surgery Orthopaedics Trauma surgeryArticle was published in
Perspectives in Surgery
2017 Issue 12
Most read in this issue
- Pulmonary contusion
- Ruptures of the diaphragm
- Myxoid liposarcoma localised in the peritoneal cavity − case report
- Chest injuries in polytraumatized children